Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?
- Correspondence to:
Eleanor J Molloy
Department of Neonatology, National Maternity Hospital, Holles St, Dublin 2, Ireland; elesean{at}hotmail.com
- Accepted 27 November 2006
Abstract
B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NTpBNP) have a major role in screening and diagnosis of cardiac disease and monitoring of the treatment response in children and adults. This review discusses the evidence underpinning the potential benefits of these natriuretic peptides in neonatology. They may serve as a useful adjunct to echocardiography in the diagnosis of patent ductus arteriosus and its response to treatment and the diagnosis of persistent pulmonary hypertension of the newborn. However, more work is needed to explore the possible roles of BNP/NTpBNP in the management of sepsis and monitoring of cardiac performance in neonates.
- BNP, B-type natriuretic peptide
- NTpBNP, N-terminal-pro-BNP
- PPHN, persistent pulmonary hypertension of the newborn
- preterm infant
- sepsis
- ventricular function
- patent ductus arteriosus
- natriuretic peptides
- BNP
- NT pro-BNP
Footnotes
-
Competing interests: None.
